Hospital Margins Squeeze as Costs Outpace Revenue Growth

Why It Matters

Tightening margins limit hospitals’ ability to invest in staff, technology, and capital projects, potentially affecting care quality and consolidation trends across the sector.

Key Takeaways

• February operating margin 1.9%, still below 3.7% target
• Expenses outpaced revenue, rising 6% YoY versus 4% revenue growth
• Drug and supply costs surged, driven by older, high‑acuity patients
• Strong commercial payer mix correlates with better hospital performance
• Outpatient growth boosts margins, but pushes high‑acuity care to hospitals

Pulse Analysis

The latest Kaufman Hall data underscores a fragile financial footing for U.S. hospitals. Operating margins slipped to just 1.9% in February, a modest rebound from January but well under the 3.7% level recorded at the end of 2025. While net operating revenue rose 5% month‑over‑month, total expenses climbed at an equal or faster pace, driven largely by non‑labor items such as drugs, supplies, and purchased services. An aging population with chronic conditions is inflating demand for high‑cost specialty pharmaceuticals, further eroding profitability.

Hospital performance now hinges on payer composition and outpatient scale. Facilities that serve a larger share of commercially insured patients enjoy steadier cash flows and can offset higher cost structures, whereas those reliant on Medicaid, Medicare or uninsured populations face tighter margins. Meanwhile, ambulatory sites are delivering positive contributions; hospitals with robust outpatient revenue streams are outperforming peers. This shift, however, creates a double‑edged sword: as routine care migrates out of the inpatient setting, hospitals are left caring for the sickest, most resource‑intensive cases, amplifying cost pressures.

The margin squeeze is likely to accelerate strategic consolidation and capital discipline across the sector. Operators may prioritize cost‑containment programs, renegotiate supplier contracts, and invest in technology that improves drug purchasing efficiency. At the same time, limited profitability could curb expansion plans and delay upgrades to facilities or electronic health‑record systems. Policymakers and insurers will be watching closely, as sustained pressure on hospital finances could impact access to care, especially in underserved regions.